Sunshine Biopharma advances K1.1 mRNA cancer-vaccine strategy
Sunshine Biopharma says it has reported in vivo tumor suppression with K1.1 mRNA and advanced a novel mRNA-cancer vaccine strategy for lung cancer.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.